Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16029-16036
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16029
Figure 1
Figure 1 Hepatic metabolism of proton pump inhibitors (except rabeprazole) (A) and metabolic pathways of proton pump inhibitors and their cytochrome P450 (CYP) isoforms involved (B).